Nevertheless, in our nested case control study where we controlled for disease activity and duration we still found a higher proportion of anti-TNFα exposure in patients with incident non-Hodgkin's lymphomas vs matched controls. This evidence concerns the gene TNF and non-Hodgkin lymphoma.